Clinical roles | |||
Australia (%) | Poland (%) | P value (Comparison of proportions between Australian and Polish participants) | |
Patient medication chart review | 28 (96.6) 29 | 3 (13.6) 22 | <0.001 |
Participation in medical ward rounds | 25 (86.2) 29 | 0 (0) 22 | <0.001 |
Monitoring the efficacy of pharmacotherapy in patients | 28 (96.6) 29 | 3 (13.6) 22 | <0.001 |
Documenting/monitoring adverse drug events/reactions | 26 (89.7) 29 | 15 (68.2) 22 | 0.056 |
Documenting medication errors | 28 (96.6) 29 | 4 (18.2) 22 | <0.001 |
Evaluating patients' clinical laboratory tests | 28 (96.6) 29 | 0 (0) 22 | <0.001 |
Therapeutic Drug Monitoring (TDM) | 28 (96.6) 29 | 3 (13.6) 22 | <0.001 |
Immunisations | 19 (67.9) 28 | 1 (4.5) 22 | <0.001 |
Monitoring Total Parenteral Nutrition (TPN) | 25 (86.2) 29 | 18 (81.8) 22 | 0.670 |
Participation in clinical meetings | 23 (79.3) 29 | 0 (0) 22 | <0.001 |
Calculating and recommending doses and dosing schedules for specific patients | 28 (96.6) 29 | 3 (13.6) 22 | <0.001 |
Assisting doctors in prescribing off-label/unlicensed medicines | 28 (96.6) 29 | 6 (27.3) 22 | <0.001 |
Identifying and performing interventions for individual patients to prevent or resolve drug therapy problems that is, interactions, incompatibilities, allergies etc. | 27 (93.1) 29 | 4 (18.2) 22 | <0.001 |
Recommending drugs and contributing to the pharmacotherapy decision making process for specific patients | 28 (96.6) 29 | 2 (9.1) 22 | <0.001 |
Collaborating and discussing specific patients with doctors and nurses | 27 (96.4) 28 | 4 (18.2) 22 | <0.001 |